glp-1 wikipedia Glucagon-like peptide-1 GLP-1 Agonists: A Comprehensive Overview
Description
No calorie counting, no crazy dietsjust simple, sustainable changes that actually worked for me
Experts estimate that this could delay progression to dialysis by 78 years in high-risk diabetic patients a potentially transformative outcome for nephrology practice
Signs you are ready to increase your dose Do not increase simply because four weeks have passed
A meta-analysis involving more than 70,000 participants with type 2 diabetes (SMART-C) found that the cardiovascular benefits of SGLT-2 inhibitors, including reductions in MACE, cardiovascular death, hospitalisation for HF, and CKD progression, were consistent regardless of whether patients were receiving a GLP-1 receptor agonist at baseline [19]
Navigating the timing of a GLP-1 (glucagon-like peptide-1) receptor agonist requires a balance between maintaining a steady level of medication in your system and making the program work for your schedule
Discuss with your provider whether this option is appropriate for your care plan
